未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
The roles and mechanism of IFIT5 in bladder cancer epithelial-mesenchymal transition and progression (vol 16, 339, 2025) IFIT5在膀胱癌上皮-间质转化及进展中的作用和机制(卷16,339,2025) Huang, Jun; Lo, U-Ging; Wu, Shiqi; Wang, Bin; Pong, Rey-Chen; Lai, Chih-Ho; Lin, Ho; He, Dalin; Hsieh, Jer-Tsong; Wu, Kaijie 分享 收藏
In situ oxygen-producing nanoplatform inducing multifunctional cell death for enhanced photodynamic therapy of hypoxic tumors 原位产氧纳米平台诱导多功能细胞死亡以增强缺氧肿瘤的光动力疗法 Wang, Wen; Qiu, Tao; Ding, Xin; He, Da-Lin; Yuan, Yi-Bo; Jiang, Meng-Kang; Long, Xin; Gao, Jia; Yin, Miao-Miao; Wang, Tian-Yu; Hu, Yan-Jun 分享 收藏
分享 收藏
Nitrogen-Doped Multiwalled Carbon Nanotubes Trigger Immune Responses and Inhibit Fat Deposition He, Dalin; Xiao, Xue; Hu, Geng; Zhang, Wenqian; Yu, Guanliu; Liu, Yan; Lin, Yun; Lin, Hai; Li, Xianyao; Diao, Youxiang; Tang, Yi; Li, Haifang 分享 收藏
Comparison of blue laser and red light-emitting diode-mediated aminolevulinic acid-based photodynamic therapy for moderate and severe acne vulgaris: A prospective, split-face, nonrandomized controlled study Fan, Hengtong; Tuo, Huihui; Xie, Yuhan; Ju, Manyu; Sun, Yan; Yang, Yajie; Han, Xinnan; Ren, Zejun; Zheng, Yan; He, Dalin 分享 收藏
分享 收藏
分享 收藏
A Novel Photosensitizer Based 450-nm Blue Laser-Mediated Photodynamic Therapy Induces Apoptosis in Colorectal Cancer - in Vitro and in Vivo Study Mei, Yibo; Gu, Lijiang; Chen, Yuhang; Zhang, Pan; Cheng, Yifan; Yuan, Renfei; Li, Xing; Wang, Xinyang; Guo, Peng; He, Dalin; Zeng, Jin 分享 收藏
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study Yan, X. Q.; Yey, M. J.; Zou, Q.; Chen, P.; He, Z. S.; Wu, B.; He, D. L.; He, C. H.; Xue, X. Y.; Ji, Z. G.; Chen, H.; Zhang, S.; Liu, Y. P.; Zhang, X. D.; Fu, C.; Xu, D. F.; Qiu, M. X.; Lv, J. J.; Huang, J.; Ren, X. B.; Cheng, Y.; Qin, W. J.; Zhang, X.; Zhou, F. J.; Ma, L. L.; Guo, J. M.; Ding, D. G.; Wei, S. Z.; He, Y.; Guo, H. Q.; Shi, B. K.; Liu, L.; Liu, F.; Hu, Z. Q.; Jin, X. M.; Yang, L.; Zhu, S. X.; Liu, J. H.; Huang, Y. H.; Xu, T.; Liu, B.; Sun, T.; Wang, Z. J.; Jiang, H. W.; Yu, D. X.; Zhou, A. P.; Jiang, J.; Luan, G. D.; Jin, C. L.; Xu, J.; Hu, J. X.; Huang, Y. R.; Guo, J.; Zhai, W.; Sheng, X. N. 分享 收藏
分享 收藏
China ARCHES: A multicenter phase III randomized doubleblind placebo (PBO)-controlled efficacy and safety trial of enzalutamide (ENZA) plus androgen deprivation therapy (ADT) vs PBO plus ADT in Chinese patients (pts) with metastatic hormone-sensitive prostate cancer (mHSPC) Zhou, F.; Gongqian, Z.; Guo, H.; Hu, Z.; Zhang, X.; He, D.; He, Z.; Zhang, D.; Li, Y.; Kadeerbai, H.; Liu, Y.; Ye, D. 分享 收藏
分享 收藏
Apalutamide for metastatic castration-sensitive prostate cancer: final analysis of the Asian subpopulation in the TITAN trial 阿帕鲁胺治疗转移性去势敏感性前列腺癌: TITAN试验中亚洲亚群的最终分析 Chung, Byung Ha; Huang, Jian; Uemura, Hiroji; Choi, Young Deuk; Ye, Zhang-Qun; Suzuki, Hiroyoshi; Kang, Taek Won; He, Da-Lin; Joung, Jae Young; Brookman-May, Sabine D.; McCarthy, Sharon; Bhaumik, Amitabha; Singh, Anildeep; Mundle, Suneel; Chowdhury, Simon; Agarwal, Neeraj; Ye, Ding-Wei; Chi, Kim N.; Uemura, Hirotsugu 分享 收藏
Proxalutamide in metastatic castration-resistant prostate cancer: Primary analysis of a multicenter, randomized, open-label, phase 2 trial 普罗沙鲁胺治疗转移性去势抵抗性前列腺癌: 一项多中心、随机、开放标签、2期试验的初步分析 Zhou, Tie; Qin, Shengfei; Xu, Weidong; Tang, Shouyan; Chen, Guanghua; Li, Song; Hou, Jianguo; Gao, Xu; Shi, Guowei; Sun, Zhongquan; Jin, Jie; Chen, Lijun; Sun, Weibing; Liu, Ben; Wang, Jingen; Meng, Qinggui; Wang, Dongwen; Hu, Zhiquan; He, Dalin; Yang, Yong; Song, Xishuang; Fu, Cheng; Wang, Yinhuai; Ye, Dingwei; Zhang, Wei 分享 收藏
Photoactivatable metal organic framework for synergistic ferroptosis and photodynamic therapy using 450 nm laser 使用450 nm激光进行协同铁死亡和光动力治疗的光活化金属有机框架 Chen, Yuhang; Gu, Lijiang; Ma, Bohan; Li, Xing; Mei, Yibo; Zhou, Jinlai; Chong, Yue; Ma, Minghai; Zhang, Mengzhao; Wang, Lu; Cheng, Yifan; Wu, Kaijie; Zeng, Jin; Cheng, Ming; Guo, Peng; Zhang, Penghui; He, Dalin 分享 收藏